Additional Details

  • H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

    NIEHS Clinical Research Unit (CRU)
    Research Triangle Park NC. 27709
    View Details

  • The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis

    University of Virginia
    Charlottesville VA. 22908
    View Details

  • Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients with IPF

    Southeastern Research Center
    Winston Salem NC. 27103
    View Details

  • Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients with IPF

    MUSC Pulmonary Research
    Charleston SC. 29425
    View Details

  • Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients with IPF

    Montefiore Medical Center
    Bronx NY. 10467
    View Details

  • Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients with IPF

    Mayo Clinic
    Jacksonville FL. 32224
    View Details

  • Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients with IPF

    Newport Native MD, Inc.
    Newport Beach CA. 92663
    View Details

  • Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

    University of Michigan
    Ann Arbor MI. 48109
    View Details

  • Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

    University of Virginia
    Charlottesville VA. 22908
    View Details

  • Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

    Massachusetts General Hospital
    Boston MA. 02114
    View Details

  • Move With Air: Physiological Response Assessment

    Centre of Innovative Medicine of the McGill University Health Centre
    Montreal QC. H4A 3J1
    View Details

  • Move With Air: Exercise Training Study

    Centre of Innovative Medicine of the McGill University Health Centre
    Montreal QC. H4A 3J1
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Temple University
    Philadelphia PA. 19140
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    UCLA Health Westwood Medical Plaza
    Westwood CA. 90095
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Cleveland Clinic
    Cleveland OH. 44195
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Royal University Hospital (Saskatoon)
    Saskatoon SK. S7N 0W8
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Northern Westchester Hospital
    Mount Kisco NY. 10549
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    St. Joseph's Healthcare Hamilton
    Hamilton ON. L8N 1Y2
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Georgetown University
    Washington DC. 20007
    View Details

  • A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

    Centre Hospitalier de l'Universite de Montreal (CHUM)
    Montreal QC. H2X 0C1
    View Details